GBIO
Price
$0.30
Change
-$0.06 (-16.67%)
Updated
Jun 27 closing price
Capitalization
20.14M
38 days until earnings call
PRLD
Price
$0.82
Change
-$0.04 (-4.65%)
Updated
Jun 27 closing price
Capitalization
46.3M
45 days until earnings call
Interact to see
Advertisement

GBIO vs PRLD

Header iconGBIO vs PRLD Comparison
Open Charts GBIO vs PRLDBanner chart's image
Generation Bio
Price$0.30
Change-$0.06 (-16.67%)
Volume$7.39M
Capitalization20.14M
Prelude Therapeutics
Price$0.82
Change-$0.04 (-4.65%)
Volume$1.85M
Capitalization46.3M
GBIO vs PRLD Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. PRLD commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GBIO: $0.30 vs. PRLD: $0.82)
Brand notoriety: GBIO and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 1118% vs. PRLD: 1075%
Market capitalization -- GBIO: $22.46M vs. PRLD: $46.3M
GBIO [@Biotechnology] is valued at $22.46M. PRLD’s [@Biotechnology] market capitalization is $46.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while PRLD’s TA Score has 2 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 5 bearish.
  • PRLD’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than PRLD.

Price Growth

GBIO (@Biotechnology) experienced а -20.95% price change this week, while PRLD (@Biotechnology) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

PRLD is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRLD($46.3M) has a higher market cap than GBIO($20.1M). PRLD YTD gains are higher at: -35.678 vs. GBIO (-71.660). GBIO has higher annual earnings (EBITDA): -69.2M vs. PRLD (-138.2M). GBIO has more cash in the bank: 158M vs. PRLD (99.1M). PRLD has less debt than GBIO: PRLD (17.9M) vs GBIO (87.6M). GBIO has higher revenues than PRLD: GBIO (24.6M) vs PRLD (7M).
GBIOPRLDGBIO / PRLD
Capitalization20.1M46.3M43%
EBITDA-69.2M-138.2M50%
Gain YTD-71.660-35.678201%
P/E RatioN/AN/A-
Revenue24.6M7M351%
Total Cash158M99.1M159%
Total Debt87.6M17.9M489%
TECHNICAL ANALYSIS
Technical Analysis
GBIOPRLD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPRN31.590.76
+2.47%
Princeton Bancorp
BL56.640.11
+0.19%
BlackLine
GHLD19.73N/A
N/A
Guild Holdings Company
GEHC74.38-0.48
-0.64%
GE HealthCare Technologies
FGEN5.22-0.08
-1.51%
FibroGen Inc

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-15.40%
CCCC - GBIO
50%
Loosely correlated
-7.89%
ATXS - GBIO
50%
Loosely correlated
N/A
IDYA - GBIO
48%
Loosely correlated
-4.13%
ATNM - GBIO
48%
Loosely correlated
-12.35%
IPSC - GBIO
47%
Loosely correlated
-5.74%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with HUMA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then HUMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-4.64%
HUMA - PRLD
36%
Loosely correlated
-4.50%
GBIO - PRLD
36%
Loosely correlated
-15.40%
MGTX - PRLD
36%
Loosely correlated
-0.90%
ATNM - PRLD
35%
Loosely correlated
-12.35%
ITOS - PRLD
34%
Loosely correlated
-0.70%
More